News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,042 Results
Type
Article (87097)
Company Profile (704)
Press Release (768221)
Multimedia
Podcasts (158)
Webinars (21)
Section
Business (232925)
Career Advice (4136)
Deals (39772)
Drug Delivery (132)
Drug Development (91155)
Employer Resources (200)
FDA (18226)
Job Trends (17378)
News (397065)
Policy (39868)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (126)
Alzheimer's disease (1625)
Antibody-drug conjugate (ADC) (196)
Approvals (18201)
Artificial intelligence (424)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (141)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (418)
Cancer (3336)
Cardiovascular disease (268)
Career advice (3545)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (605)
Cervical cancer (27)
Clinical research (74659)
Collaboration (1204)
Company closure (4)
Compensation (804)
Complete response letters (44)
COVID-19 (2924)
CRISPR (71)
C-suite (432)
Cystic fibrosis (127)
Data (3410)
Decentralized trials (2)
Denatured (57)
Depression (87)
Diabetes (395)
Diagnostics (7018)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (197)
Drug pricing (166)
Drug shortages (36)
Duchenne muscular dystrophy (173)
Earnings (98554)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131812)
Executive appointments (936)
FDA (20323)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1074)
Gene editing (154)
Generative AI (42)
Gene therapy (480)
GLP-1 (974)
Government (5319)
Grass and pollen (7)
Guidances (326)
Healthcare (20925)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3132)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (146)
Interviews (813)
IPO (17911)
IRA (59)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (65)
Layoffs (613)
Leadership (28)
Legal (10141)
Liver cancer (88)
Longevity (12)
Lung cancer (463)
Lymphoma (235)
Machine learning (16)
Management (65)
Manufacturing (508)
MASH (112)
Medical device (14789)
Medtech (14801)
Mergers & acquisitions (22642)
Metabolic disorders (1017)
Multiple sclerosis (108)
NASH (23)
Neurodegenerative disease (168)
Neuropsychiatric disorders (48)
Neuroscience (2456)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (53)
Obesity (511)
Opinion (300)
Ovarian cancer (109)
Pain (138)
Pancreatic cancer (139)
Parkinson's disease (209)
Partnered (27)
Patents (361)
Patient recruitment (219)
Peanut (55)
People (65907)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23027)
Phase II (32409)
Phase III (24411)
Pipeline (2293)
Policy (270)
Postmarket research (3554)
Preclinical (10401)
Press Release (72)
Prostate cancer (162)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (568)
Real estate (7404)
Recruiting (76)
Regulatory (27472)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (13)
RSV (62)
Schizophrenia (113)
Series A (179)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4311)
State (2)
Stomach cancer (17)
Supply chain (88)
Tariffs (80)
The Weekly (99)
Vaccines (971)
Venture capital (62)
Weight loss (351)
Women's health (53)
Worklife (20)
Date
Today (93)
Last 7 days (553)
Last 30 days (2760)
Last 365 days (33972)
2025 (21581)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (50676)
Australia (8903)
California (8452)
Canada (2577)
China (780)
Colorado (362)
Connecticut (379)
Delaware (230)
Europe (116347)
Florida (1267)
Georgia (291)
Hawaii (3)
Idaho (67)
Illinois (771)
India (39)
Indiana (410)
Iowa (19)
Japan (253)
Kansas (120)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1175)
Massachusetts (6418)
Michigan (289)
Minnesota (523)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (95)
New Hampshire (75)
New Jersey (2341)
New Mexico (31)
New York (2323)
North Carolina (1310)
North Dakota (10)
Northern California (3719)
Ohio (270)
Oklahoma (17)
Oregon (49)
Pennsylvania (1796)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (40)
South Dakota (1)
Southern California (3174)
Tennessee (136)
Texas (1320)
United States (31643)
Utah (250)
Virginia (229)
Washington D.C. (81)
Washington State (730)
West Virginia (4)
Wisconsin (89)
There are 856,042 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Restart Life Sciences Provides Corporate Update on Strategy and Growth Initiatives
August 21, 2025
·
3 min read
Press Releases
AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
August 21, 2025
·
18 min read
Press Releases
Health Canada grants marketing authorization for an additional indication of Bayer’s NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC)
August 21, 2025
·
6 min read
Press Releases
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
August 21, 2025
·
1 min read
Press Releases
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
August 21, 2025
·
1 min read
Press Releases
DAWNZERA™ (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema
August 21, 2025
·
8 min read
Press Releases
Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025
August 21, 2025
·
6 min read
Press Releases
Agilent to Participate in 2025 Wells Fargo Healthcare Conference
August 21, 2025
·
1 min read
Press Releases
Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer
August 21, 2025
·
2 min read
Press Releases
Verantos to Present Practical Approaches in High-Validity Real-World Evidence Generation at ISPE’s 41st Annual Meeting
August 21, 2025
·
1 min read
1 of 85,605
Next
